282 related articles for article (PubMed ID: 35406791)
1. Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?
Lesire L; Leroux F; Deprez-Poulain R; Deprez B
Cells; 2022 Apr; 11(7):. PubMed ID: 35406791
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the Activity of the Insulin-Degrading Enzyme by Aβ Peptides.
Kemeh MM; Lazo ND
ACS Chem Neurosci; 2023 Aug; 14(16):2935-2943. PubMed ID: 37498802
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
Bennett RG; Hamel FG; Duckworth WC
Diabetes; 1997 Feb; 46(2):197-203. PubMed ID: 9000694
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
Maianti JP; McFedries A; Foda ZH; Kleiner RE; Du XQ; Leissring MA; Tang WJ; Charron MJ; Seeliger MA; Saghatelian A; Liu DR
Nature; 2014 Jul; 511(7507):94-8. PubMed ID: 24847884
[TBL] [Abstract][Full Text] [Related]
5. Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases.
Sousa L; Guarda M; Meneses MJ; Macedo MP; Vicente Miranda H
J Pathol; 2021 Dec; 255(4):346-361. PubMed ID: 34396529
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity.
Fernández-Díaz CM; Merino B; López-Acosta JF; Cidad P; de la Fuente MA; Lobatón CD; Moreno A; Leissring MA; Perdomo G; Cózar-Castellano I
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E805-E819. PubMed ID: 31479304
[TBL] [Abstract][Full Text] [Related]
7. Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme.
Ivancic VA; Krasinski CA; Zheng Q; Meservier RJ; Spratt DE; Lazo ND
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305381
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.
González-Casimiro CM; Merino B; Casanueva-Álvarez E; Postigo-Casado T; Cámara-Torres P; Fernández-Díaz CM; Leissring MA; Cózar-Castellano I; Perdomo G
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33477364
[TBL] [Abstract][Full Text] [Related]
9. Non-covalent interaction of ubiquitin with insulin-degrading enzyme.
Saric T; Müller D; Seitz HJ; Pavelic K
Mol Cell Endocrinol; 2003 Jun; 204(1-2):11-20. PubMed ID: 12850277
[TBL] [Abstract][Full Text] [Related]
10. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
Duckworth WC; Bennett RG; Hamel FG
Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
[TBL] [Abstract][Full Text] [Related]
11. Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
Leissring MA; Malito E; Hedouin S; Reinstatler L; Sahara T; Abdul-Hay SO; Choudhry S; Maharvi GM; Fauq AH; Huzarska M; May PS; Choi S; Logan TP; Turk BE; Cantley LC; Manolopoulou M; Tang WJ; Stein RL; Cuny GD; Selkoe DJ
PLoS One; 2010 May; 5(5):e10504. PubMed ID: 20498699
[TBL] [Abstract][Full Text] [Related]
12. From virus to diabetes therapy: Characterization of a specific insulin-degrading enzyme inhibitor for diabetes treatment.
Nash Y; Ganoth A; Borenstein-Auerbach N; Levy-Barazany H; Goldsmith G; Kopelevich A; Pozyuchenko K; Sakhneny L; Lazdon E; Blanga-Kanfi S; Alhadeff R; Benromano T; Landsman L; Tsfadia Y; Frenkel D
FASEB J; 2021 May; 35(5):e21374. PubMed ID: 33835493
[TBL] [Abstract][Full Text] [Related]
13. A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase.
Duckworth WC; Bennett RG; Hamel FG
J Biol Chem; 1994 Oct; 269(40):24575-80. PubMed ID: 7929129
[TBL] [Abstract][Full Text] [Related]
14. Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.
Çakir B; Dağliyan O; Dağyildiz E; Bariş İ; Kavakli IH; Kizilel S; Türkay M
PLoS One; 2012; 7(2):e31787. PubMed ID: 22355395
[TBL] [Abstract][Full Text] [Related]
15. Possible Role of Insulin-Degrading Enzyme in the Physiopathology of Retinitis Pigmentosa.
Sánchez-Cruz A; Hernández-Fuentes MD; Murillo-Gómez C; de la Rosa EJ; Hernández-Sánchez C
Cells; 2022 May; 11(10):. PubMed ID: 35626658
[TBL] [Abstract][Full Text] [Related]
16. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme.
Bennett RG; Fawcett J; Kruer MC; Duckworth WC; Hamel FG
J Endocrinol; 2003 Jun; 177(3):399-405. PubMed ID: 12773120
[TBL] [Abstract][Full Text] [Related]
17. Differential Effects of Polyphenols on Insulin Proteolysis by the Insulin-Degrading Enzyme.
Zheng Q; Kebede MT; Lee B; Krasinski CA; Islam S; Wurfl LA; Kemeh MM; Ivancic VA; Jakobsche CE; Spratt DE; Lazo ND
Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34572974
[TBL] [Abstract][Full Text] [Related]
18. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
19. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
Hamel FG; Fawcett J; Tsui BT; Bennett RG; Duckworth WC
Diabetes Obes Metab; 2006 Nov; 8(6):661-8. PubMed ID: 17026490
[TBL] [Abstract][Full Text] [Related]
20. Insulin-degrading enzyme.
Authier F; Posner BI; Bergeron JJ
Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
